Imfinzi (durvalumab) plus 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel — a chemotherapy regimen known as “FLOT” — outperformed placebo plus FLOT ...
Xtandi plus Pluvicto improved PSA progression-free survival in certain patients with prostate cancer, research showed.Patients with metastatic ...
The shortage of Pluvicto (lutetium Lu 177 vipivotide tetraxetan) — a PSMA-targeted therapy that was approved by the Food and Drug Administration (FDA) in ...
The Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application for MB-109 to treat patients with recurrent glioblastoma (GBM) ...
Fatigue is a common side effect experienced by patients with myeloproliferative neoplasms. Patients with myeloproliferative neoplasms (MPNs) may experience ...
CARY, NC (October 19, 2023) - Celebrating a decade of riding for patients, more than 126 Bristol Myers Squibb (NYSE: BMY) employees have completed the 10th ...
Throughout our lives, our bodies act as intricate timepieces, marking the passage of time with unwavering hands. However, for some women, removing ovaries ...
Toby Keith announced upcoming tour dates post stomach cancer diagnosis.Country star Toby Keith has announced that he will be preforming two concerts on Dec. ...
Earlier this year, we announced work on our Manifesto for Cancer Research & Care– a blueprint made up of clear, actionable long-term policies to ...
Rashid K. Sayyid, MD, MSc, discusses the role of combination therapy in metastatic castrate-resistant prostate cancer.
Shay Elkins, a patient with metastatic triple-negative breast cancer, discussed her experience with second-line treatment. Dr. Noor provided insights into ...
Practical advice for improving clinical trials to ensure they are more reflective of the overall population of patients with prostate cancer.